Preparation and characterization of nanoparticles based on histidine-Hyaluronic acid conjugates as doxorubicin carriers

Journal of Materials Science: Materials in Medicine

Volumn 23, Issue 8, 2012, Pages 1921-1929

  Wu, Jing Liang ^a,b   Liu, Chen Guang ^a   Wang, Xiao Lei ^a   Huang, Zhen Hua ^a  

^a OCEAN UNIVERSITY OF CHINA   (China)

^b WEIFANG MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CELL LINES; CARBODIIMIDES; COUPLING REACTION; CRITICAL AGGREGATION CONCENTRATION; CYTOTOXICITY TEST; DEGREE OF SUBSTITUTION; DOXORUBICIN; HYALURONIC ACIDS; HYDROPHILIC SEGMENTS; HYDROPHOBIC SEGMENT; MCF-7 CELLS; SEM IMAGE; STRUCTURAL CHARACTERISTICS; TIME-DEPENDENT; TRANSMISSION ELECTRON MICROSCOPY TEM;

CELL CULTURE; FLUORESCENCE MICROSCOPY; FLUORESCENCE SPECTROSCOPY; NANOPARTICLES; SCANNING ELECTRON MICROSCOPY; TRANSMISSION ELECTRON MICROSCOPY;

AMINO ACIDS;

DOXORUBICIN; DRUG CARRIER; HISTIDINE; HYALURONIC ACID; NANOPARTICLE;

ARTICLE; CYTOTOXICITY; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG SYNTHESIS; FLUORESCENCE SPECTROSCOPY; HUMAN; HUMAN CELL; LIGHT SCATTERING; PARTICLE SIZE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SCANNING ELECTRON MICROSCOPY; TRANSMISSION ELECTRON MICROSCOPY;

ANTIBIOTICS, ANTINEOPLASTIC; BREAST NEOPLASMS; CELL LINE, TUMOR; DOXORUBICIN; DRUG CARRIERS; FEMALE; HISTIDINE; HUMANS; HYALURONIC ACID; NANOCAPSULES;

EID: 84864924886     PISSN: 09574530     EISSN: 15734838     Source Type: Journal    
DOI: 10.1007/s10856-012-4665-8     Document Type: Article

References (34)

1. Acharya S, Sahoo SK. PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect. Adv Drug Deliv Rev. 2011;63:170-83.
2. Hwang HY, Kim IS, Kwon IC, Kim YH. Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles. J Control Release. 2008;128: 23-31.
3. Matsumura Y, Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res. 1986;46:6387-92.
4. Choi KY, Chung H, Min KH, Yoon HY, Kim K, Park JH, et al. Self-assembled hyaluronic acid nanoparticles for active tumor targeting. Biomaterials. 2010;31:106-14.
5. Park K, Lee MY, Kim KS, Hahn SK. Target specific tumor treatment by VEGF siRNA complexed with reducible polyethyleneimine-hyaluronic acid conjugate. Biomaterials. 2010;31:5258-65.
6. Patil YB, Swaminathan SK, Sadhukha T, Ma L, Panyam J. The use of nanoparticle-mediated targeted gene silencing and drug delivery to overcome tumor drug resistance. Biomaterials. 2010; 31:358-65.
7. Kobayashi T, Ishida T, Okada Y, Ise S, Harashima H, Kiwada H. Effect of transferrin receptor-targeted liposomal doxorubicin in P-glycoprotein-mediated drug resistant tumor cells. Int J Pharm. 2007;329:94-102.
8. Kirpotin DB, Drummond DC, Shao Y, Shalaby MR, Hong K, Nielsen UB, et al. Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models. Cancer Res. 2006; 66:6732-40.
9. Licciardi M, Paolino D, Celia C, Giammona G, Cavallaro G, Fresta M. Folate-targeted supramolecular vesicular aggregates based on polyaspartyl-hydrazide copolymers for the selective delivery of antitumoral drugs. Biomaterials. 2010;31:7340-54.
10. Eliaz RE, Szoka FC Jr. Liposome-encapsulated doxorubicin targeted to CD44: a strategy to kill CD44-overexpressing tumor cells. Cancer Res. 2001;61:2592-601.
11. Tan YL, Liu CG. Preparation and characterization of selfassembled nanoparticles based on folic acid modified carboxymethyl chitosan. J Mater Sci Mater Med. 2011;22:1213-20.
12. Gao W, Chan JM, Farokhzad OC. pH-responsive nanoparticles for drug delivery. Mol Pharmacol. 2010;7:1913-20.
13. Ho VH, Slater NK, Chen R. pH-responsive endosomolytic pseudo-peptides for drug delivery to multicellular spheroids tumour models. Biomaterials. 2011;32:2953-8.
14. Wang Y, Wu G, Fan Y, Ma J. pH-responsive self-assembly and conformational transition of partially propyl-esterified poly(-alpha,beta-L-aspartic acid) as amphiphilic biodegradable polyanion. Colloids Surf B. 2009;68:13-9.
15. Huh KM, Lee SC, Cho YW, Lee J, Jeong JH, Park K. Hydrotropic polymer micelle system for delivery of paclitaxel. J Control Release. 2005;101:59-68.
16. Wei H, Zhang XZ, Chen WQ, Cheng SX, Zhuo RX. Selfassembled thermosensitive micelles based on poly(L-lactide-star block-N- isopropylacrylamide) for drug delivery. J Biomed Mater Res A. 2007;83:980-9.
17. Han G, You CC, Kim BJ, Turingan RS, Forbes NS, Martin CT, et al. Light-regulated release of DNA and its delivery to nuclei by means of photolabile gold nanoparticles. Angew Chem Int Ed Engl. 2006;45:3165-9.
18. Saslawski O, Weingarten C, Benoit JP, Couvreur P. Magnetically responsive microspheres for the pulsed delivery of insulin. Life Sci. 1988;42:1521-8.
19. Rivkin I, Cohen K, Koffler J, Melikhov D, Peer D, Margalit R. Paclitaxel-clusters coated with hyaluronan as selective tumortargeted nanovectors. Biomaterials. 2010;31:7106-14.
20. He M, Zhao Z, Yin L, Tang C, Yin C. Hyaluronic acid coated poly(butyl cyanoacrylate) nanoparticles as anticancer drug carriers. Int J Pharm. 2009;373:165-73.
21. Saravanakumar G, Choi KY, Yoon HY, Kim K, Park JH, Kwon IC, et al. Hydrotropic hyaluronic acid conjugates: synthesis, characterization, and implications as a carrier of paclitaxel. Int J Pharm. 2010;394:154-61.
22. Park W, Kim KS, Bae BC, Kim YH, Na K. Cancer cell specific targeting of nanogels from acetylated hyaluronic acid with low molecular weight. Eur J Pharm Sci. 2010;40:367-75.
23. Park K, Hong SW, Hur W, Lee MY, Yang JA, Kim SW, et al. Target specific systemic delivery of TGF-beta siRNA/(PEI-SS)-g-HA complex for the treatment of liver cirrhosis. Biomaterials. 2011;32:4951-8.
24. Gao ZG, Lee DH, Kim DI, Bae YH. Doxorubicin loaded pHsensitive micelle targeting acidic extracellular pH of human ovarian A2780 tumor in mice. J Drug Target. 2005;13:391-7.
25. Lee ES, Oh KT, Kim D, Youn YS, Bae YH. Tumor pHresponsive flower-like micelles of poly(L-lactic acid)-bpoly( ethylene glycol)-b-poly(L-histidine). J Control Release. 2007;123:19-26.
26. Taluja A, Bae YH. Role of a novel excipient poly(ethylene glycol)-b-poly(L-histidine) in retention of physical stability of insulin at aqueous/organic interface. Mol Pharm. 2007;4:561-70.
27. Li YY, Chen XG, Liu CS, Cha DS, Park HJ, Lee CM. Effect of the molecular mass and degree of substitution of oleoylchitosan on the structure, rheological properties, and formation of nanoparticles. J Agric Food Chem. 2007;55:4842-7.
28. Park K, Lee GY, Kim YS, Yu M, Park RW, Kim IS, et al. Heparin-deoxycholic acid chemical conjugate as an anticancer drug carrier and its antitumor activity. J Control Release. 2006; 114:300-6.
29. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55-63.
30. Lee H, Mok H, Lee S, Oh YK, Park TG. Target-specific intracellular delivery of siRNA using degradable hyaluronic acid nanogels. J Control Release. 2007;119:245-52.
31. Jiang G, Park K, Kim J, Kim KS, Oh EJ, Kang H, et al. Hyaluronic acid-polyethyleneimine conjugate for target specific intracellular delivery of siRNA. Biopolymers. 2008;89:635-42.
32. Park JS, Han TH, Lee KY, Han SS, Hwang JJ, Moon DH, et al. N-acetyl histidine-conjugated glycol chitosan self-assembled nanoparticles for intracytoplasmic delivery of drugs: endocytosis, exocytosis and drug release. J Control Release. 2006;115:37-45.
33. Cho HJ, Yoon HY, Koo H, Ko SH, Shim JS, Lee JH, et al. Selfassembled nanoparticles based on hyaluronic acid-ceramide (HACE) and Pluronic((R)) for tumor-targeted delivery of docetaxel. Biomaterials. 2011;32:7181-90.
34. Elizabeth RG. Frechet JMJ pH-Responsive copolymer assemblies for controlled release of doxorubicin. Bioconjug Chem. 2005;16: 361-8.